Poseida Therapeutics, Inc.
Clinical trials sponsored by Poseida Therapeutics, Inc., explained in plain language.
-
Scientists test 'Ready-Made' cell therapy in major push against incurable blood cancer
Disease control Recruiting nowThis early-stage trial is testing the safety of a new type of cell therapy called P-BCMA-ALLO1 in adults with multiple myeloma that has come back or stopped responding to standard treatments. The therapy uses genetically modified immune cells from a donor, not the patient, aiming…
Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test 'Ready-Made' cell therapy for Tough-to-Treat blood cancers
Disease control Recruiting nowThis is an early-stage safety study testing a new type of cell therapy called P-CD19CD20-ALLO1 for adults with aggressive B-cell lymphomas that have come back or not responded to standard treatments. The therapy uses genetically modified immune cells from a donor (not the patient…
Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC